Menten AI
menten.ai
Actively hiring
Drug Discovery
Drug Discovery AI
As featured in
Follow
Overview
News
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Team
6
US Form 5500 (plan participants) · Dec 2025 · +100% in a year
Backers
1
Y Combinator
Momentum
0/100
no fresh signals
Last sign of life
this month
a posting or a news item
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Tractionpublic signals, read monthly
Web presence
top 0.11%
of 133.2M domains by links, Common Crawl
Backed byfrom the funds' portfolios and accelerator catalogs
Y Combinator Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers
MOLCURE is an AI company that accelerates drug discovery by combining machine learning, biotechnology and robotics. Its antibody discovery…
ProteinQure is a Toronto biotechnology company founded in 2017 that designs peptide therapeutics computationally. Its platform combines…
Genesis Molecular AI is a drug discovery company headquartered in Burlingame, California, and founded in 2019. The company combines deep…
Xaira Therapeutics uses generative models for protein design and drug discovery. It launched with one of the largest initial funding rounds…
Gordian Biotechnology is a biotechnology company that generates in vivo perturbation data across more than 1000 targets in diseases such as…
Latent Labs builds generative models that design proteins from a natural language description of the desired function. Founded in 2023 by a…
Overview
Menten AI designs peptide therapeutics using computational protein design combined with quantum and classical optimisation. Founded in 2018 in San Francisco, it generates candidate sequences and validates them in its own laboratory. The company focuses on peptide binders for targets that small molecules struggle to reach.
News
September 8, 2025 Menten AI Adds Quantum Computing to Develop New Drugs The startup, backed by Y Combinator among others, aims to develop biologics, or drugs made from organic rather than synthetic material Read more
The startup, backed by Y Combinator among others, aims to develop biologics, or drugs made from organic rather than synthetic material
Read more
Report
September 8, 2025 How Business Can Use Quantum Computing Right Now (Not 10 Years Into The Future) CEO of PCIS. Entrepreneur with a deep focus on technology. Helping companies strategize, innovate and grow. Read more
CEO of PCIS. Entrepreneur with a deep focus on technology. Helping companies strategize, innovate and grow.
Read more
Report
Menten AI Leverages AWS, AI, and Quantum Computing to Create New and Improved Drugs AWS Startups
Learn how Menten AI is leveraging AWS, AI, and quantum computing to transform drug discovery. Explore the future of personalized and improved medicine.
Read more
Report
September 8, 2025 Terramera Leads Collaborative Effort to Predict New COVID-19 Virus Strains With Machine Learning and AI Government backs joint project to avoid future pandemics with better forecasting and pre-design of effective vaccines, antibodies and tests Read more
Government backs joint project to avoid future pandemics with better forecasting and pre-design of effective vaccines, antibodies and tests
Read more
Report
Macrocyclic peptides: Aiming for the perfect fit
The hunt for drugs that are big enough to interact with proteins but small enough to negotiate cell membranes is coming full circle
Read more
Report
May 28, 2024 Menten AI Announces Completion of Research Collaboration with Bristol Myers Squibb A collaboration with BMS leverages Menten AI's generative AI platform to accelerate the design and optimization of peptide macrocycles. Read more
A collaboration with BMS leverages Menten AI's generative AI platform to accelerate the design and optimization of peptide macrocycles.
Read more
Report
Show more news
Offices
Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
San Francisco
United States
HQ
10-50 est. staff